一种导致血小板减少症4型的新型CYCS基因变异降低半胱天冬酶活性:三代家系研究
研究报道一个捷克家系三代中与血小板减少症共分离的新型CYCS变异c.59C>T [p.(Thr20Ile)],患者表型符合血小板减少症4型(THC4),血小板大小形态正常、呈显性遗传,且血小板计数逐代下降。将变异引入MEG-01巨核母细胞系后,变异降低CYCS表达、增加线粒体呼吸和CD9表达,并降低半胱天冬酶活性,与其他已知CYCS变异的作用相反。
要点
- 新型CYCS变异c.59C>T [p.(Thr20Ile)]在捷克家系三代中与血小板减少症共分离。
- 患者表型符合THC4:血小板大小形态正常、显性遗传,血小板计数逐代下降。
- 该变异降低CYCS表达、增加线粒体呼吸和CD9表达,并降低半胱天冬酶活性。
核心结论
- 该新型CYCS变异在捷克家系三代中与血小板减少症共分离,患者表型符合THC4。
- 变异降低CYCS表达、增加线粒体呼吸和CD9表达,并降低半胱天冬酶活性,与其他已知CYCS变异的作用相反。
- 半胱天冬酶活性失调可能参与血小板减少症的发生。
研究设计与样本
- 研究为一个捷克家系三代的家系研究,并采用CRISPR/Cas9介导的基因编辑将新CYCS变异引入巨核母细胞系MEG-01。
- 对携带该变异的细胞分析了黏附、形态、大小、倍性、活力、线粒体呼吸、细胞色素c蛋白(CYCS)表达、细胞表面抗原表达和半胱天冬酶活性。
主要发现
- 患者表型符合THC4,血小板大小和形态正常,呈显性遗传。
- 家系三代中观察到血小板计数逐代下降。
- 变异降低CYCS表达,同时增加线粒体呼吸和CD9细胞表面抗原表达。
- 变异降低半胱天冬酶活化,与其他已知CYCS变异的作用相反。
临床怎么用
- 研究发现可增进对遗传性血小板减少症分子机制的理解,并可能对诊断、预后和未来靶向治疗有启示。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The CYCS gene is highly evolutionarily conserved, with only a few pathogenic variants that cause thrombocytopenia-4 (THC4). Here, we report a novel CYCS variant NM_018947.6: c.59C>T [NP_061820.1:p.(Thr20Ile)] segregating with thrombocytopenia in three generations of a Czech family. The phenotype of the patients corresponds to THC4 with platelets of normal size and morphology and dominant inheritance. Intriguingly, a gradual decline in platelet counts was observed across generations. CRISPR/Cas9-mediated gene editing was used to introduce the new CYCS gene variant into a megakaryoblast cell line (MEG-01). Subsequently, the adhesion, shape, size, ploidy, viability, mitochondrial respiration, cytochrome c protein (CYCS) expression, cell surface antigen expression and caspase activity were analysed in cells carrying the studied variant. Interestingly, the variant decreases the expression of CYCS while increasing mitochondrial respiration and the expression of CD9 cell surface antigen. Surprisingly, the variant abates caspase activation, contrasting with previously known effects of other CYCS variants. Some reports indicate that caspases may be involved in thrombopoiesis; thus, the observed dysregulation of caspase activity might contribute to thrombocytopenia. The findings significantly enhance our understanding of the molecular mechanisms underlying inherited thrombocytopenia and may have implications for diagnosis, prognosis and future targeted therapies.
引用
- Štika J, Pešová M, Kozubík KS, et al. A novel thrombocytopenia-4-causing CYCS gene variant decreases caspase activity: Three-generation study. Br J Haematol. 2024. PMID: 39191490. doi:10.1111/bjh.19694
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。